Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
13F holders, Q1 2024
Institutional positions in Aspire Biopharma Holdings, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q4 2023
- Shares held
- 1.64M
- +67.7K (+4.3%) vs. Q4 2023
- Total value
- $18.1M
- +$1.87M (+11.5%) vs. Q4 2023
- New holders
- 5
- 3 more added
- Sold out
- 6
- 2 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $250.9K |
| Q1 2026 | 15 | $371.9K |
| Q4 2025 | 30 | $899.8K |
| Q3 2025 | 25 | $645.6K |
| Q2 2025 | 16 | $544.7K |
| Q1 2025 | 15 | $875.8K |
| Q4 2024 | 3 | $5.36M |
| Q3 2024 | 2 | $149.6K |
| Q2 2024 | 3 | $90.4K |
| Q1 2024 | 19 | $18.1M |
| Q4 2023 | 21 | $17.9M |
| Q3 2023 | 21 | $18.2M |
| Q2 2023 | 14 | $17.0M |
| Q1 2023 | 59 | $267.9M |
| Q4 2022 | 57 | $264.7M |
| Q3 2022 | 61 | $260.8M |
| Q2 2022 | 54 | $243.4M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fir Tree Capital Management LP | 212,815 | $2.35M | 0.98% | +31,837+17.6% | Added |
| Periscope Capital Inc. | 175,000 | $1.93M | 0.51% | 00.0% | Unchanged |
| Arena Investors LP | 150,000 | $1.66M | 67.20% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 150,000 | $1.66M | 0.01% | 00.0% | Unchanged |
| CNH Partners LLC | 150,000 | $1.65M | 0.06% | 00.0% | Unchanged |
| Exos Asset Management LLC | 150,000 | $1.65M | 0.98% | +150,000 | New |
| LMR Partners LLP | 150,000 | $1.65M | 0.04% | 00.0% | Unchanged |
| Vivaldi Asset Management, LLC | 128,449 | $1.41M | 0.12% | 00.0% | Unchanged |
| Cowen and Company, LLC | 117,717 | $1.30M | 0.05% | +117,717 | New |
| First Pacific Advisors, LP | 56,966 | $628.3K | 0.01% | +56,966 | New |
| Clear Street LLC | 50,777 | $559.3K | 0.02% | +50,777 | New |
| Glazer Capital, LLC | 39,809 | $439.0K | 0.05% | +9,170+29.9% | Added |
| Quarry LP | 36,200 | $400.2K | 0.16% | +35,000+2,916.7% | Added |
| Westchester Capital Management, LLC | 36,029 | $397.4K | 0.02% | 00.0% | Unchanged |
| Tuttle Tactical Management | 17,000 | $187.3K | 1.45% | 00.0% | Unchanged |
| Robinson Capital Management, LLC | 10,162 | $113.7K | 0.04% | −320−3.1% | Reduced |
| Toroso Investments, LLC | 10,111 | $111.8K | 0.00% | −320−3.1% | Reduced |
| BlackRock Inc. | 300 | $3.31K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 50 | $552 | 0.00% | +50 | New |
| P Schoenfeld Asset Management LP | 0 | $0 | 0.00% | −133,234−100.0% | Sold out |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −102,184−100.0% | Sold out |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −63,251−100.0% | Sold out |
| Sea Otter Advisors LLC | 0 | $0 | 0.00% | −1,120−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Cohanzick Management, LLC | 0 | $0 | 0.00% | −83,333−100.0% | Sold out |
| Exos TFP Holdings LLC | – | – | – | – | Not filed |